FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1710343815> ?p ?o ?g. }

• W1710343815 endingPage "322" @default.
• W1710343815 startingPage "313" @default.
• W1710343815 abstract "Aims Albendazole (ABZ; methyl 5‐propylthio‐1H‐benzimidazol‐2‐yl carbamate) is a broad spectrum anthelmintic whose activity resides both in the parent compound and its sulphoxide metabolite (ABS). There are numerous reports of ABZ metabolism in animals but relatively few in humans. We have investigated the sulphoxidation of ABZ in human liver microsomes and recombinant systems. Methods The specific enzymes involved in the sulphoxidation of ABZ were determined by a combination of approaches; inhibition with an antiserum directed against cytochrome P450 reductase, the effect of selective chemical inhibitors on ABZ sulphoxidation in human liver microsomes, the capability of expressed CYP and FMO to mediate the formation of ABS, regression analysis of the rate of metabolism of ABZ to ABS in human liver microsomes against selective P450 substrates and regression analysis of the rate of ABS sulphoxidation against CYP expression measured by Western blotting. Results Comparison of V max values obtained following heat inactivation (3min at 45°C) of flavin monoxygenases (FMO), chemical inhibition of FMO with methimazole and addition of an antiserum directed against cytochrome P450 reductase indicate that FMO and CYP contribute ≈ 30% and 70%, respectively, to ABS production in vitro . Comparison of CL int values suggests CYP is a major contributor in vivo . A significant reduction in ABZ sulphoxidation ( n = 3) was seen with ketoconazole (CYP3 A4; 32–37%), ritonavir (CYP3 A4: 34–42%), methimazole (FMO: 28–49%) and thioacetamide (FMO; 32–35%). Additive inhibition with ketoconazole and methimazole was 69 ± 8% ( n = 3). ABS production in heat – treated microsomes (3 min at 45 °C) correlated significantly with testosterone 6β‐hydroxylation (CYP3A4; P < 0.05) and band intensities on Western blots probed with an antibody selective for 3A4 ( P < 0.05). Recombinant human CYP3 A4, CYP1A2 and FMO3 produced ABS in greater quantities than control microsomes, with those expressing CYP3A4 producing threefold more ABS than those expressing CYP1A2. Kinetic studies showed the K m values obtained with both CYP3A4 and FMO3 were similar. Conclusions We conclude that the production of ABS in human liver is mediated via both FMO and CYP, principally CYP3A4, with the CYP component being the major contributor." @default.
• W1710343815 created "2016-06-24" @default.
• W1710343815 creator A5008381642 @default.
• W1710343815 creator A5009706312 @default.
• W1710343815 creator A5061252066 @default.
• W1710343815 creator A5067396225 @default.
• W1710343815 date "2000-04-01" @default.
• W1710343815 modified "2023-10-03" @default.
• W1710343815 title "Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes" @default.
• W1710343815 cites W1125033069 @default.
• W1710343815 cites W1532212858 @default.
• W1710343815 cites W1765706822 @default.
• W1710343815 cites W1775749144 @default.
• W1710343815 cites W1888082628 @default.
• W1710343815 cites W1951469402 @default.
• W1710343815 cites W1974023170 @default.
• W1710343815 cites W1977308510 @default.
• W1710343815 cites W1987710224 @default.
• W1710343815 cites W1989360506 @default.
• W1710343815 cites W1999730565 @default.
• W1710343815 cites W2012483302 @default.
• W1710343815 cites W2018365669 @default.
• W1710343815 cites W2037812043 @default.
• W1710343815 cites W2049770869 @default.
• W1710343815 cites W2055255308 @default.
• W1710343815 cites W2064799851 @default.
• W1710343815 cites W2078387155 @default.
• W1710343815 cites W2083051020 @default.
• W1710343815 cites W2097515374 @default.
• W1710343815 cites W2114845550 @default.
• W1710343815 cites W2123384291 @default.
• W1710343815 cites W2131614625 @default.
• W1710343815 cites W2139400706 @default.
• W1710343815 cites W2140847119 @default.
• W1710343815 cites W2163879184 @default.
• W1710343815 cites W2240258872 @default.
• W1710343815 cites W2404428481 @default.
• W1710343815 cites W2497438609 @default.
• W1710343815 doi "https://doi.org/10.1046/j.1365-2125.2000.00170.x" @default.
• W1710343815 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2014938" @default.
• W1710343815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10759686" @default.
• W1710343815 hasPublicationYear "2000" @default.
• W1710343815 type Work @default.
• W1710343815 sameAs 1710343815 @default.
• W1710343815 citedByCount "114" @default.
• W1710343815 countsByYear W17103438152012 @default.
• W1710343815 countsByYear W17103438152013 @default.
• W1710343815 countsByYear W17103438152014 @default.
• W1710343815 countsByYear W17103438152015 @default.
• W1710343815 countsByYear W17103438152016 @default.
• W1710343815 countsByYear W17103438152017 @default.
• W1710343815 countsByYear W17103438152018 @default.
• W1710343815 countsByYear W17103438152019 @default.
• W1710343815 countsByYear W17103438152020 @default.
• W1710343815 countsByYear W17103438152021 @default.
• W1710343815 countsByYear W17103438152022 @default.
• W1710343815 countsByYear W17103438152023 @default.
• W1710343815 crossrefType "journal-article" @default.
• W1710343815 hasAuthorship W1710343815A5008381642 @default.
• W1710343815 hasAuthorship W1710343815A5009706312 @default.
• W1710343815 hasAuthorship W1710343815A5061252066 @default.
• W1710343815 hasAuthorship W1710343815A5067396225 @default.
• W1710343815 hasBestOaLocation W17103438152 @default.
• W1710343815 hasConcept C11824378 @default.
• W1710343815 hasConcept C13002179 @default.
• W1710343815 hasConcept C134651460 @default.
• W1710343815 hasConcept C181199279 @default.
• W1710343815 hasConcept C185592680 @default.
• W1710343815 hasConcept C2776146729 @default.
• W1710343815 hasConcept C2777477808 @default.
• W1710343815 hasConcept C2779548794 @default.
• W1710343815 hasConcept C2781064554 @default.
• W1710343815 hasConcept C526171541 @default.
• W1710343815 hasConcept C55493867 @default.
• W1710343815 hasConcept C62231903 @default.
• W1710343815 hasConcept C86803240 @default.
• W1710343815 hasConcept C87644729 @default.
• W1710343815 hasConcept C89311334 @default.
• W1710343815 hasConcept C89423630 @default.
• W1710343815 hasConceptScore W1710343815C11824378 @default.
• W1710343815 hasConceptScore W1710343815C13002179 @default.
• W1710343815 hasConceptScore W1710343815C134651460 @default.
• W1710343815 hasConceptScore W1710343815C181199279 @default.
• W1710343815 hasConceptScore W1710343815C185592680 @default.
• W1710343815 hasConceptScore W1710343815C2776146729 @default.
• W1710343815 hasConceptScore W1710343815C2777477808 @default.
• W1710343815 hasConceptScore W1710343815C2779548794 @default.
• W1710343815 hasConceptScore W1710343815C2781064554 @default.
• W1710343815 hasConceptScore W1710343815C526171541 @default.
• W1710343815 hasConceptScore W1710343815C55493867 @default.
• W1710343815 hasConceptScore W1710343815C62231903 @default.
• W1710343815 hasConceptScore W1710343815C86803240 @default.
• W1710343815 hasConceptScore W1710343815C87644729 @default.
• W1710343815 hasConceptScore W1710343815C89311334 @default.
• W1710343815 hasConceptScore W1710343815C89423630 @default.
• W1710343815 hasIssue "4" @default.
• W1710343815 hasLocation W17103438151 @default.
• W1710343815 hasLocation W17103438152 @default.

• next